Can You Advertise TRT on Google?

What this means for you

• An in-person men's health clinic can run Google Search ads today on clinic, lab and consultation intent, and may name testosterone in US ad text and on the landing page without certification.
• Bidding on keywords that contain prescription drug terms needs Google certification. Plan as if any keyword containing "testosterone" counts.
• A telehealth TRT program is a prescription drug service under Google's policy. It needs LegitScript Healthcare Merchant Certification and then Google's own certification before its ads serve.
• Google bars hCG promoted in conjunction with anabolic steroids, certified or not. Testosterone is an anabolic steroid under federal law.
• Health and prescription drug campaigns can't use customer match, remarketing lists or lookalike segments.

MedScale Health, a paid acquisition agency for telehealth brands and clinics, plans Google campaigns for men's health clinics and telehealth TRT programs. This page sets out the Google policies that decide whether a TRT brand can advertise on Search, what the ads can say, and what the account can bid on. This page is marketing guidance, not medical or legal advice. Platform policies change, so check the sources listed at the end before acting on a specific rule.

Gate 1: is the business a prescription drug service?

Google restricts the promotion of services related to the online prescribing, dispensing and sale of prescription drugs, and names online pharmacies and telemedicine providers among the businesses covered. Google decides whether an advertiser is in scope from its ads, its site and the services it offers, and says it errs on the side of caution with landing pages that appear to facilitate online prescribing. A page that offers an online assessment, a remote visit and testosterone shipped home is in scope, whatever the ad says.

For the United States, Google allows telemedicine providers accredited through LegitScript's Healthcare Merchant Certification Program, which offers telemedicine certification to websites that provide virtual healthcare services and facilitate prescribing. The advertiser must then be certified by Google as well. Google asks for the application at the child account level, not the manager account, with the customer ID and the certified domain, and warns against applying for a category that does not match the business model. An in-person clinic whose site books office visits, and does not prescribe online, sits outside this gate for its clinic ads.

Gate 2: naming testosterone versus bidding on it

Google's restricted drug terms policy has a specific rule for campaigns targeting the United States, Canada or New Zealand: "While you don't need to be certified in order to use prescription drug terms in ads and landing pages, you must be certified in order to keyword-target these terms." Certification is also required for certain business types, including online pharmacies and telemedicine providers, whatever the ad text says.

Google's prescription drug services policy says only approved advertisers may bid on keywords containing prescription drug terms, and Google's non-exhaustive list of monitored drugs includes testosterone products such as Depo-Testosterone and AndroGel. Read "containing" literally and treat testosterone as a drug term when you plan keywords: "low testosterone doctor" and "testosterone clinic near me" both contain it. Until the account holds a certification that covers keyword targeting, campaigns bid on clinic intent instead, such as men's health clinic, hormone testing and men's hormone clinic, plus the city name. The ad text and the landing page can still say testosterone therapy.

Gate 3: testosterone is a controlled substance

Testosterone is listed among the anabolic steroids in Schedule III of the federal controlled substances schedules (21 CFR 1308.13). Prescribing a controlled substance by telemedicine without an in-person evaluation relies on the DEA's temporary flexibilities, and the fourth extension (Federal Register document 2025-24123) keeps them in effect from January 1 through December 31, 2026. Ads and landing pages that promise a start with no in-person visit at all should be written so they still hold if those rules change.

LegitScript's write-up of its telehealth advertising webinar adds the creative point: testosterone carries heightened regulatory scrutiny, and platforms are attuned to messaging that frames it as a performance enhancer rather than a hormone treatment. Muscle, physique and stamina angles invite review problems. Labs, clinicians and follow-up care do not.

Gate 4: substances Google refuses outright

Google's unapproved substances policy applies regardless of certification. Its list includes products containing human chorionic gonadotropin (hCG) in relation to weight loss, or when promoted in conjunction with anabolic steroids; products that imply they are as effective as prescription drugs or controlled substances; herbal and dietary supplements with active pharmaceutical ingredients; and products that have been subject to any government or regulatory action or warning.

For a TRT program that means hCG never appears beside testosterone in an ad or on the page the ad sends people to, and no supplement in the same funnel is pitched as a natural alternative that works like a prescription. Any compounded testosterone formulation is compounded, not FDA-approved, and should be described that way wherever it is named.

Gate 5: audiences

Google's personalized advertising policy treats health as a sensitive interest category, including physical health conditions, sexual health and treatments for chronic conditions, and treats prescription medication content as a sensitive category of its own under restricted drug terms. Advertisers promoting in a sensitive category can't use advertiser-curated audiences: customer match, your data segments, audience expansion and lookalike segments. Predefined Google audiences, such as in-market, affinity and life events, remain available, and nobody under 18 is eligible for personalized ads of any kind. A TRT account runs on keywords, location and broad signals, and no patient list is ever uploaded.

What still gets rejected

• Telehealth TRT ads that run before LegitScript and Google certification are both in place.
• Keywords containing testosterone or a testosterone brand name, bid on without certification.
• Landing pages that sell testosterone without a prescription step. Google treats offering prescription drugs without a prescription as an unauthorized pharmacy violation.
• hCG promoted alongside testosterone, and supplements pitched as working like testosterone.
• Performance, muscle and physique claims.

The consequences differ. Google says prescription drug services violations bring a warning at least seven days before any account suspension. Unauthorized pharmacy violations are egregious: the account is suspended on detection, without prior warning, and Google says reinstatement happens only in compelling circumstances.

What MedScale does

MedScale Health runs Google Search for TRT in this order: a policy read of every keyword, ad and landing page; clinic and lab-intent campaigns that can run now; landing pages that say a prescription is required and a licensed provider decides; and, for telehealth models, LegitScript certification help and the Google application alongside the campaigns that can already run. MedScale tracks server-side under a BAA with neutral event names, and no names, emails, phone numbers, IP addresses or browser IDs go to any ad platform. No approval or result is guaranteed. Start with the free growth audit at medscale.health/audit for a written read of your account against these rules.